Career Timeline of Vivek Ramaswamy: Major Achievements and Milestones

How Vivek Ramaswamy built a successful career. Explore key moments that defined the journey.

Vivek Ganapathy Ramaswamy is an American entrepreneur and politician. He founded the pharmaceutical company Roivant Sciences in 2014, serving as CEO until 2021. He entered national politics as a presidential candidate in the 2024 Republican primaries. After withdrawing, he endorsed Donald Trump. Ramaswamy is now the Republican nominee for Governor of Ohio for the 2026 elections with endorsements from President Trump and the Ohio Republican Party.

Sections (3)

Full Timeline Early Life & Education Career & Achievements

2007: Joined QVT Financial

From 2007, Ramaswamy worked at the hedge fund QVT Financial.

2007: Co-founded Campus Venture Network

In 2007, Ramaswamy and Travis May co-founded Campus Venture Network, which created a social networking website for aspiring student entrepreneurs.

2009: Sale of Campus Venture Network

In 2009, Campus Venture Network, co-founded by Ramaswamy, was sold to the Ewing Marion Kauffman Foundation.

December 2014: Axovant Purchased Intepirdine Patent

In December 2014, Axovant, a Roivant subsidiary, purchased the patent for intepirdine from GlaxoSmithKline for $5 million, after it had failed four clinical trials.

2014: Founded Roivant Sciences

In 2014, Ramaswamy founded Roivant Sciences after working as an investment partner at a hedge fund.

2014: Left QVT Financial

In 2014, Ramaswamy left QVT Financial, where he was a partner and co-managed the firm's biotech portfolio.

March 2015: Chairman of OnCore and Tekmira

In March 2015, Ramaswamy was chairman of OnCore Biopharma and maintained his position at Tekmira Pharmaceuticals after the two companies merged.

2015: Forbes Cover and Capital Gains

In 2015, Ramaswamy appeared on the cover of Forbes, touted Axovant's IPO, and claimed over $37 million in capital gains after selling shares in Roivant to Viking Global Investors. He claimed his company would be the "Berkshire Hathaway of drug development".

September 2017: Intepirdine Trial Failure

In September 2017, Axovant announced that intepirdine failed in its large clinical trial, causing the company's value to plunge by 75% in one day.

2017: Roivant Partnered with CITIC and SoftBank Invested

In 2017, Roivant partnered with CITIC Private Equity of the Chinese state-owned CITIC Group to form Sinovant, and SoftBank invested $1.1 billion in Roivant.

2018: Roivant Foundation Created

In 2018, an earlier iteration of Roivant Social Ventures (RSV), the Roivant Foundation, was created.

2019: Sale of Subsidiaries

In 2019, Roivant sold its stake in five subsidiaries to Sumitomo Dainippon Pharma, resulting in Ramaswamy making $175 million in capital gains, and giving Sumitomo Dainippon a 10% stake in Roivant.

2020: Co-founded Chapter Medicare

In 2020, Ramaswamy co-founded Chapter Medicare, a Medicare navigation platform, and participated in the Ohio COVID-19 Response Team.

2020: Roivant Social Ventures Established

In 2020, Roivant Sciences, under Ramaswamy's CEO leadership, established a nonprofit social-impact arm, Roivant Social Ventures (RSV).

January 2021: Stepped Down as CEO

In January 2021, Ramaswamy stepped down as CEO of Roivant Sciences, becoming executive chairman.

August 2021: Publishes Woke Inc

In August 2021, Vivek Ramaswamy's book, the New York Times bestseller, "Woke Inc", described his view of the so-called "modern woke-industrial complex".

2021: Authored "Woke, Inc."

In 2021, Ramaswamy wrote his first book, "Woke Inc", and appeared on cable networks to argue against left-wing "woke" policies. "Woke, Inc." is a book by Vivek Ramaswamy.

2021: Stepped down as CEO of Roivant Sciences

In 2021, Vivek Ramaswamy stepped down as the chief executive officer of Roivant Sciences.

September 2022: Published "Nation of Victims"

In September 2022, Ramaswamy published his second book, "Nation of Victims: Identity Politics, the Death of Merit, and the Path Back to Excellence", before announcing his presidential candidacy. "Nation of Victims" is a book written by Vivek Ramaswamy.

Nation of Victims: Identity Politics, the Death of Merit, and the Path Back to Excellence

Check it on Amazon

October 2022: Meetings with South Carolina Lawmakers

In October 2022, Ramaswamy held closed-door meetings with South Carolina lawmakers to pitch Strive to manage the state's pension funds, arranged by state treasurer Curtis Loftis.

2022: Considered running for U.S. Senate in Ohio

In 2022, Ramaswamy briefly considered running in the U.S. Senate election in Ohio.

2022: Co-founded Strive Asset Management

In 2022, Ramaswamy co-founded Strive Asset Management, an investment firm.

2022: Launched DRLL Fund

In 2022, Strive launched its flagship fund, the exchange-traded fund DRLL, as an "anti-woke" energy sector index fund. Ramaswamy stated Strive would encourage energy companies to maximize success regardless of political or social agendas.

February 2023: Resigned from Strive

In February 2023, Ramaswamy resigned as executive chairman of Strive to focus on his presidential campaign.

February 2023: Resigned as Chair of Roivant

In February 2023, Ramaswamy stepped down as chair of Roivant to focus on his presidential campaign.

February 21, 2023: Ramaswamy Announces Presidential Candidacy

On February 21, 2023, Vivek Ramaswamy announced his candidacy for the Republican nomination for president of the United States in the 2024 election on Tucker Carlson Tonight and publicly released 20 years of his income tax returns.

2023: Axovant Dissolved

In 2023, Axovant, which had attempted to reinvent itself as a gene therapy company, dissolved.

2023: Promises to Pardon Trump

In 2023, after Trump was indicted on federal criminal charges, Vivek Ramaswamy promised to pardon Trump if elected president.

May 2024: Acquired Stake in BuzzFeed

In May 2024, Ramaswamy acquired a 7.7% stake in BuzzFeed, later increased to 8.4%, becoming the second-largest Class A shareholder and suggested hiring conservative pundits and new directors.

2024: Ramaswamy Tasked to Lead DOGE

A week after the 2024 election, President-elect Donald Trump announced that Ramaswamy and Elon Musk had been tasked to lead the newly proposed Department of Government Efficiency (DOGE). However, Ramaswamy never worked with the DOGE team during the Trump administration, as on Inauguration Day, he dropped out of DOGE.

2024: Presidential Candidacy and Endorsement

In 2024, Vivek Ramaswamy entered national politics as the youngest presidential candidate in the Republican primaries, later withdrawing his bid and endorsing Donald Trump for the 2024 presidential election.

2024: Ramaswamy Ends Campaign and Endorses Trump

In January of 2024, after finishing fourth in the Iowa caucuses, Vivek Ramaswamy ended his campaign and endorsed Donald Trump. For the remainder of the 2024 U.S. presidential election, Ramaswamy served the Trump campaign as a political surrogate.

February 15, 2025: Files to Enter 2026 Ohio Gubernatorial Election

On February 15, 2025, Vivek Ramaswamy filed to enter the 2026 Ohio gubernatorial election and received an endorsement from President Donald Trump.

May 9, 2025: Receives Endorsement of Ohio Republican Party

On May 9, 2025, Vivek Ramaswamy received the official endorsement of the Ohio Republican Party's State Central Committee for his gubernatorial run.

January 6, 2026: Announces Running Mate

On January 6, 2026, Vivek Ramaswamy announced that he had selected Ohio State Senate President Rob McColley as his running mate for lieutenant governor.

May 5, 2026: Wins Republican Primary

On May 5, 2026, in the Republican primary, Vivek Ramaswamy defeated Casey Putsch, 82.5% to 17.5%.

2026: Focus on Ohio Gubernatorial Campaign

In 2024, Vivek Ramaswamy dropped out of DOGE to focus on a potential 2026 Ohio gubernatorial campaign due to friction with DOGE leadership and staff.

2026: Republican Nominee for Governor of Ohio

In 2026, Vivek Ramaswamy became the Republican nominee for Governor of Ohio, receiving endorsements from President Trump and the Ohio Republican Party.